(0 items)
Small Medium Large | Print-Friendly Version of this Page  | Email this Page to a Friend
Skip Navigation Links
Press Releases
Hot Topics
Statements
Comments
Correspondence
White Papers
Contact Public Relations
AABB > Press Room > Statements

Statements Archive 

2008

Statement Before NRC on the Use of Alternative Forms of CsCl Sources and Alternative Technologies – 9/30/08
Statement Before NRC on the Possible Phase Out of CsCl Sources – 9/30/08
Statement Before NRC on Additional Requirements for Enhanced Security of CsCl Sources – 9/30/08
Statement Before BPAC on Blood Donor Deferral for Travel to Malarious Areas – 9/11/08
Joint Statement Before ACBSA on the Clinical Significance of Red Cell Age in Transfusions – 5/30/08
Statement of AABB Before BPAC on WNV – 5/1/08 (PDF)
Presentation Before the Advisory Council on Blood and Stem Cell Transplantation on AABB Cord Blood Standards and Accreditation Programs – 4/28/08 (PDF)

2007

Joint Statement by Civilian and Military Blood Programs – 10/16/07
Statement Before CMS Advisory Panel on Ambulatory Payment Classification Groups on Bone Marrow and Stem Cell Processing Procedures – 9/6/07
Statement of AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism Before ACBSA on Ensuring Transfusion and Transplantation Safety During Blood Shortages – 8/22/07 (PDF)
Joint Statement on Military Blood Donations – 7/23/07
Statement Before the Cellular, Tissue and Gene Therapies Advisory Committee – 3/30/07

2006

Joint Statement on National Drug Code for HCT/Ps – 12/11/06
Joint Statement Before TSEAC on Donor Screening Tests for vCJD – 9/19/06
Statement Before ACBSA on Support for a U.S. Hemovigilance/Biovigilance Program – 5/9/06
Joint Statement Before ACBSA on Prescription Drug Marketing Act – 5/1/06
Joint Statement Before BPAC on Behavior-Based Blood Donors Deferrals in the Era of Nucleic Acid Testing (NAT) – 3/9/06
Statement Before BPAC on Rapid Tests for Detection of Bacterial Contamination of Platelets – 3/9/06

2005

Joint Statement Before BPAC on Management of Donors and Units that Test Positive for HBV DNA by NAT – 7/21/05
Statement Before BPAC on Production of Plasma Products – 3/17/05
Statement Before TSEAC on European Transfusion Deferral – 2/8/05

2004

Joint Statement Before BPAC on West Nile Virus Donor Deferral – 10/22/04
Joint Statement Before BPAC on HBC Re-Entry – 10/22/04
Joint Statement Before BPAC on Supplemental HIV/HCV Testing – 10/21/04
Joint Statement Before BPAC on Simian Foamy Virus – 10/21/04
Statement Before BPAC on HBV NAT – 7/23/04
Statement Before BPAC on TRALI – 7/22/04
Statement Before BPAC on Dating of Irradiated Blood Products – 7/22/04
Statement Before BPAC on New Standard for Platelet Evaluation – 7/22/04
Statement Before BPAC on Blood Pressure Lower Limit – 7/22/04
Statement Before BPAC on Platelet Pheresis Quality Control – 3/19/04
Statement Before BPAC on HIV-HCV Supplemental Testing – 3/18/04

2003

Statement Before BPAC on Donor Protection –12/12/03
Joint Statement Before BPAC on Labeling and Storage Requirements – 12/12/03
Statement Before BPAC on Abbreviated Donor History Questionnaire – 12/11/03
Joint Statement Before BPAC on Leishmania – 12/11/03
Statement Before BPAC on SARS, HIV Group O, Labeling and Storage Requirements and White Particulate Matter – 9/18/03
Statement Before BPAC on White Particulate Matter – 6/19/03
Statement Before BPAC on SARS – 6/19/03
Statement on Use of Plasticizer DEHP in PVC Blood Bags – 6/03
Statement Before TSEAC on Lack of Data on the Status of the U.S. Blood Supply – 2/20/03

2002

Statement Before BPAC on NAT for Human Parvovirus B-19 – 12/12/02
Statement Before BPAC on Chagas' Disease – 9/12/02
Statement Before House Committee on Blood Supply and Disaster Preparedness – 9/10/02
Statement Before BPAC on Tattoo and Body Piercing – 3/14/02
Joint Statement Before Secretary’s Advisory Committee on Xenotransplantation – 3/12/02

2001

Statement Before BPAC on Leukocyte Reduction Guidance – 12/13/01
Statement Before ACBSA on Blood Supply and Utilization Data – 8/24/01
Statement Before BPAC on Re-entry for Donors Deferred for HIV/HCV Test Results – 6/14/01
Statement Before ACBSA on Blood Supply and Utilization Data Collection – 4/20/01

2000

Statement Before BPAC on Donor Deferral Policy for Male to Male Sex – 9/14/00
Statement Before BPAC on Syphilis Testing – 9/14/00
Statement Before BPAC on the Risk of HCV to Sexual Partners – 6/16/00
Statement Before BPAC on HAV NAT – 6/15/00
Statement Before ACBSA on Reimbursement for Blood Products and Services – 4/26/00
Statement Before BPAC on History of Hepatitis in Blood and Plasma Donors – 3/16/00
Statement Before the Xenotransplantation Subcommittee of the Biological Response Modifiers Advisory Committee – 1/13/00

1999

Statement Before BPAC on HTLV Supplemental Tests – 6/18/99

1997

Statement Before BPAC on Effect of Leukoreduction on CMV Transmission Through Blood Transfusion – 9/19/97

Home  |  Site Map  | AABB © 2014. All rights reserved. |  Privacy Statement  |  Terms of Use